Cart
sales@molnova.com
Epoxiconazole
CAS No. 133855-98-8
Epoxiconazole( BAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2 )
Catalog No. M27138 CAS No. 133855-98-8
Epoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 39 | In Stock |
|
| 25MG | 70 | In Stock |
|
| 50MG | 90 | In Stock |
|
| 100MG | 146 | In Stock |
|
| 200MG | 220 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEpoxiconazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
DescriptionEpoxiconazole is a 14-α demethylase inhibitor. It inhibits ergosterol synthesis and fungal cell wall formation.
-
In Vitro——
-
In Vivo——
-
SynonymsBAS 480F | BAS480F | BAS-480F | EC 406 850 2 | EC-406-850-2
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptorδ-opioid receptor| μ-opioid receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number133855-98-8
-
Formula Weight329.76
-
Molecular FormulaC17H13ClFN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (303.25 mM)
-
SMILESFc1ccc(cc1)C1(Cn2cncn2)OC1c1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mónica García, et al. Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ 1 Receptor Antagonist Clinical Candidate for the Treatment of Pain. J Med Chem. 2020 Oct 16.
molnova catalog
related products
-
Zidebactam
Zidebactam is an effective β-lactamase inhibitor.
-
Phthalocyanine
Phthalocyanine (29H,31H-Phthalocyanine) is an important multifunctional dye.
-
Ceforanide
Ceforanide is a second-generation cephalosporin antibiotic with bactericidal activity. Ceforanide causes inhibition of bacterial cell wall synthesis by inactivating penicillin binding proteins (PBPs) thereby interfering with the final transpeptidation step required for cross-linking of peptidoglycan units which are a component of the cell wall.
